Search research articles
Contact Us
Filters
Showing results (131-140 of 249) with videos related to
Page
of 25
Sort By:
The American Journal of Dermatopathology
|
July 28, 2006
Cytogenetic and molecular analysis of 12 cases of primary cutaneous marginal zone lymphomas
Arnaud de la Fouchardiere, Sophie Gazzo, Brigitte Balme, et al.
Journal of Geriatric Oncology
|
September 28, 2013
First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis
Anne-Sophie Michallet, Bruno Cazin, Emmanuel Bouvet, et al.
Przeglad Lekarski
|
June 22, 2006
[The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas]
Ewa Kalinka, Przemysław Juszczyński, Grzegorz Woszczek, et al.
Journal of Clinical Pharmacology
|
January 21, 2014
Population pharmacokinetics of ofatumumab in patients with chronic lymphocytic leukemia, follicular lymphoma, and rheumatoid arthritis
Herbert Struemper, Mark Sale, Bela R Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2003
Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study
Bertrand Coiffier, Nicolas Mounier, Serge Bologna, et al.
Annales De Pathologie
|
June 29, 2005
[Pathological and clinical correlations in primary cutaneous B-cell lymphomas: a series of 44 cases]
Arnaud de la Fouchardière, Brigitte Balme, Brigitte Chouvet, et al.
Haematologica
|
July 6, 2014
A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders
Gabriel Brisou, Aurélie Verney, Thomas Wenner, et al.
Genes, Chromosomes & Cancer
|
February 22, 2007
Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma
Jacek Nowak, Ewa Kalinka-Warzocha, Przemyslaw Juszczynski, et al.
Leukemia & Lymphoma
|
May 27, 2004
Maintenance therapy with a monthly injection of alemtuzumab prolongs response duration in patients with refractory B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL)
Catherine Thieblemont, Fadhela Bouafia, Emmanuel Hornez, et al.
Medicine
|
September 18, 2007
Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients
Florence Lachenal, Francoise Berger, Hervé Ghesquières, et al.
Page
of 25
Search research articles
Search
Showing results (131-140 of 249) with videos related to
Sort By:
Page
of 25
The American Journal of Dermatopathology
|
July 28, 2006
Cytogenetic and molecular analysis of 12 cases of primary cutaneous marginal zone lymphomas
Arnaud de la Fouchardiere, Sophie Gazzo, Brigitte Balme, et al.
Journal of Geriatric Oncology
|
September 28, 2013
First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis
Anne-Sophie Michallet, Bruno Cazin, Emmanuel Bouvet, et al.
Przeglad Lekarski
|
June 22, 2006
[The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas]
Ewa Kalinka, Przemysław Juszczyński, Grzegorz Woszczek, et al.
Journal of Clinical Pharmacology
|
January 21, 2014
Population pharmacokinetics of ofatumumab in patients with chronic lymphocytic leukemia, follicular lymphoma, and rheumatoid arthritis
Herbert Struemper, Mark Sale, Bela R Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2003
Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study
Bertrand Coiffier, Nicolas Mounier, Serge Bologna, et al.
Annales De Pathologie
|
June 29, 2005
[Pathological and clinical correlations in primary cutaneous B-cell lymphomas: a series of 44 cases]
Arnaud de la Fouchardière, Brigitte Balme, Brigitte Chouvet, et al.
Haematologica
|
July 6, 2014
A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders
Gabriel Brisou, Aurélie Verney, Thomas Wenner, et al.
Genes, Chromosomes & Cancer
|
February 22, 2007
Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma
Jacek Nowak, Ewa Kalinka-Warzocha, Przemyslaw Juszczynski, et al.
Leukemia & Lymphoma
|
May 27, 2004
Maintenance therapy with a monthly injection of alemtuzumab prolongs response duration in patients with refractory B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL)
Catherine Thieblemont, Fadhela Bouafia, Emmanuel Hornez, et al.
Medicine
|
September 18, 2007
Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients
Florence Lachenal, Francoise Berger, Hervé Ghesquières, et al.
Page
of 25